-
Single neutron transfer on 23Ne and its relevance forthepathway ofnucleosynthesis in astrophysical X-ray bursts
Authors:
G. Lotay,
J. Henderson,
W. N. Catford,
F. A. Ali,
J. Berean,
N. Bernier,
S. S. Bhattacharjee,
M. Bowry,
R. Caballero-Folch,
B. Davids,
T. E. Drake,
A. B. Garnsworthy,
F. GhaziMoradi,
S. A. Gillespie,
B. Greaves,
G. Hackman,
S. Hallam,
D. Hymers,
E. Kasanda,
D. Levy,
B. K. Luna,
A. Mathews,
Z. Meisel,
M. Moukaddam,
D. Muecher
, et al. (10 additional authors not shown)
Abstract:
We present new experimental measurements of resonance strengths in the astrophysical 23Al(p, γ)24Si reaction, constraining the pathway of nucleosynthesis beyond 22Mg in X-ray burster scenarios. Specifically, we have performed the first measurement of the (d, p) reaction using a radioactive beam of 23Ne to explore levels in 24Ne, the mirror analog of 24Si. Four strong single-particle states were ob…
▽ More
We present new experimental measurements of resonance strengths in the astrophysical 23Al(p, γ)24Si reaction, constraining the pathway of nucleosynthesis beyond 22Mg in X-ray burster scenarios. Specifically, we have performed the first measurement of the (d, p) reaction using a radioactive beam of 23Ne to explore levels in 24Ne, the mirror analog of 24Si. Four strong single-particle states were observed and corresponding neutron spectroscopic factors were extracted with a precision of {\sim}20{\%}. Using these spectroscopic factors, together with mirror state identifications, we have reduced uncertainties in the strength of the key {\ell} = 0 resonance at Er= 157 keV, in the astrophysical 23Al(p, γ) reaction, by a factor of 4. Our results show that the 22Mg(p, γ)23Al(p, γ) pathway dominates over the competing 22Mg(α, p) reaction in all but the most energetic X-ray burster events (T>0.85GK), significantly affecting energy production and the preservation of hydrogen fuel.
△ Less
Submitted 17 August, 2022;
originally announced August 2022.
-
First Direct Measurement of an Astrophysical p-Process Reaction Cross Section Using a Radioactive Ion Beam
Authors:
G. Lotay,
S. A. Gillespie,
M. Williams,
T. Rauscher,
M. Alcorta,
M. Amthor,
C. A. Andreoiu,
D. Baal,
G. C. Ball,
S. S. Bhattacharjee,
H. Behnamian,
V. Bildstein,
C. Burbadge,
W. N. Catford,
D. T. Doherty,
N. E. Esker,
F. H. Garcia,
A. B. Garnsworthy,
G. Hackman,
S. Hallam,
K. A. Hudson,
S. Jazrawi,
E. Kasanda,
A. R. L. Kennington,
Y. H. Kim
, et al. (13 additional authors not shown)
Abstract:
We have performed the first direct measurement of the 83Rb(p,g) radiative capture reaction cross section in inverse kinematics using a radioactive beam of 83Rb at incident energies of 2.4 and 2.7 A MeV. The measured cross section at an effective relative kinetic energy of Ecm = 2.393 MeV, which lies within the relevant energy window for core collapse supernovae, is smaller than the prediction of s…
▽ More
We have performed the first direct measurement of the 83Rb(p,g) radiative capture reaction cross section in inverse kinematics using a radioactive beam of 83Rb at incident energies of 2.4 and 2.7 A MeV. The measured cross section at an effective relative kinetic energy of Ecm = 2.393 MeV, which lies within the relevant energy window for core collapse supernovae, is smaller than the prediction of statistical model calculations. This leads to the abundance of 84Sr produced in the astrophysical p process being higher than previously calculated. Moreover, the discrepancy of the present data with theoretical predictions indicates that further experimental investigation of p-process reactions involving unstable projectiles is clearly warranted.
△ Less
Submitted 14 September, 2021;
originally announced September 2021.
-
Intra- and Inter-Fraction Relative Range Verification in Heavy-Ion Therapy Using Filtered Interaction Vertex Imaging
Authors:
Devin Hymers,
Eva Kasanda,
Vinzenz Bildstein,
Joelle Easter,
Andrea Richard,
Artemis Spyrou,
Cornelia Höhr,
Dennis Mücher
Abstract:
Heavy-ion therapy, particularly using scanned (active) beam delivery, provides a precise and highly conformal dose distribution, with maximum dose deposition for each pencil beam at its endpoint (Bragg peak), and low entrance and exit dose. To take full advantage of this precision, robust range verification methods are required; these methods ensure that the Bragg peak is positioned correctly in t…
▽ More
Heavy-ion therapy, particularly using scanned (active) beam delivery, provides a precise and highly conformal dose distribution, with maximum dose deposition for each pencil beam at its endpoint (Bragg peak), and low entrance and exit dose. To take full advantage of this precision, robust range verification methods are required; these methods ensure that the Bragg peak is positioned correctly in the patient and the dose is delivered as prescribed. Relative range verification allows intra-fraction monitoring of Bragg peak spacing to ensure full coverage with each fraction, as well as inter-fraction monitoring to ensure all fractions are delivered consistently. To validate the proposed filtered Interaction Vertex Imaging method for relative range verification, a ${}^{16}$O beam was used to deliver 12 Bragg peak positions in a 40 mm poly-(methyl methacrylate) phantom. Secondary particles produced in the phantom were monitored using position-sensitive silicon detectors. Events recorded on these detectors, along with a measurement of the treatment beam axis, were used to reconstruct the sites of origin of these secondary particles in the phantom. The distal edge of the depth distribution of these reconstructed points was determined with logistic fits, and the translation in depth required to minimize the $χ^2$ statistic between these fits was used to compute the range shift between any two Bragg peak positions. In all cases, the range shift was determined with sub-millimeter precision, to a standard deviation of the mean of 220(10) $μ$m. This result validates filtered Interaction Vertex Imaging as a reliable relative range verification method, which should be capable of monitoring each energy step in each fraction of a scanned heavy-ion treatment plan.
△ Less
Submitted 17 December, 2021; v1 submitted 16 June, 2021;
originally announced June 2021.
-
GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker
Authors:
Eva Kasanda,
Christine Burbadge,
Vinzenz Bildstein,
Josef Turko,
Artemis Spyrou,
Cornelia Höhr,
Dennis Mücher
Abstract:
In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, $^{92}$Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions betwee…
▽ More
In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, $^{92}$Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions between the proton beam and marker nucleus result in the emission of delayed characteristic $γ$ rays, which are detected off-beam for an improved signal-to-noise ratio. In order to determine the viability of this technique and to establish an experimental setup for future work, the Monte Carlo package GEANT4 was used in combination with ROOT to simulate a treatment scenario with the new method outlined in this work. These simulations show that analyzing the intensity of delayed $γ$ rays produced from competing reactions yields a precise measurement of the range of the proton beam relative to the marker, with sub-millimeter uncertainty.
△ Less
Submitted 2 February, 2020;
originally announced February 2020.
